Skip to content
Is anything going to get in the way of the stock market’s rally? Even as the U.S. is expected to report a serious quarterly drop in GDP and unemployment rates remain at elevated levels, the market’s leap forward hasn’t been derailed, with the S&P 500 up 45% since hitting a low point on March 23.At the same time, the rate of new COVID-19 cases is climbing at a record-breaking pace, making it clear that the virus will be with us for some time. Given this alarming disconnect, it has become even more challenging to predict where the market might be heading.That’s not to say there aren’t any compelling plays out there. Against this backdrop, the pros from investment firm Goldman Sachs argue that a select few actually stand to gain, pointing to two stocks in particular that represent exciting opportunities.While the firm’s analysts believe both are poised to surge at least...
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On......
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is......
With a median price-to-earnings (or "P/E") ratio of close to 16x in the United States, you could be forgiven for......
(Bloomberg) -- After securing more than $20 billion in investment from the likes of Google and Facebook Inc., Indian billionaire Mukesh Ambani laid out a vision for his digital venture as he seeks to build a homegrown technology titan that could rival global giants.Outlining plans for Jio Platforms Ltd. at the annual shareholders meeting of his conglomerate Reliance Industries Ltd. on Wednesday, Asia’s richest man talked mostly technology. He unveiled a slew of services, including a fifth-generation wireless network as early as next year and a mega video-streaming platform that will bring Netflix, Disney+ Hotstar, Amazon Prime and dozens of other TV channels under one umbrella.“I believe that the time has come for a truly global digital product and services company to emerge from India, and to be counted among the best in the world,” the tycoon told the 300,000-plus people who logged into the virtual conference from 41 countries.Ambani, 63,...
AbbVie Inc (NYSE: ABBV) shares popped Tuesday after researchers found that the large-cap pharma's cholesterol-lowering drug Tricor could work against SARS-CoV2, the virus that causes COVID-19.What Happened: Researchers at Israel's Hebrew University and the Mount Sinai Medical Center in New York said FDA-approved Tricor could potentially downgrade COVID-19's severity into "nothing worse than a common cold," Israeli media reported.Tricor impairs the replicating potential of the new coronavirus or even could eradicate it, the reports said, citing Hebrew University professor Ya'acov Nahmias and Sinai's Dr. Benjamin tenOever.See Also: Moderna's Stock Jumps After Coronavirus Vaccine Shows Positive Results In Phase 1 Clinical TrialHow Tricor Acts: Following three months of in vitro, or lab, studies and a review of eight already approved drugs, the researchers found that Tricor burns fat, causing the virus to disappear with merely five days of treatment.SARS-Co-V2 was found to impede with the carbohydrate metabolism, leading to the accumulation of...
